Dr. Abdulfatah Abdul Issak, MD

Dr. Issak practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Issak's NPI, 1720406325, was assigned on April 1, 2014. Dr. Issak holds Ohio license 35129731.

Dr. Issak's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Issak's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Issak is also affiliated with Medina Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Issak to 3 more hospitals, 3 medical groups, 2 clinical labs and 2 group practices and clinics, each named with a free account. Dr. Issak's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Issak practices, 9 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Issak's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Issak is licensed in Ohio.

CMS data shows 182 Medicare services from Dr. Issak across 10 procedure codes in 2024, for 198 Medicare patients. Medicare paid $20,554 for them.

CMS counts 198 Medicare patients who saw Dr. Issak in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Issak's median patient age at 62, with 51% women.

In 2024, Dr. Issak wrote 188 Medicare Part D claims for 148 patients. 90% of them were for generic drugs. CMS names the drug for 146 of them, across 2 drugs with 11 or more claims each, at $2,549 in total drug cost. In 2023, CMS named 62 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Issak for performance year 2024, reported through an alternative payment model (APM). Dr. Issak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 200 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Issak, more than 90% of the clinicians it reports for that procedure.

CMS Open Payments shows 23 general payments to Dr. Issak from 12 drug and device companies from 2016 to 2025. Grants make up the largest share, 94% of the total. Boston Scientific Corporation paid the most, $27,369.